Clls stock price

Author: njxq

August undefined, 2024

WebCrispr Therapeutics stock opened the day at $45.00 after a previous close of $45.40. The latest price was $45.09 (25-minute delay). Crispr Therapeutics is listed on the NASDAQ, has a trailing 12-month revenue of around USD1.2 million and employs 458 staff. Market capitalization: $3,523,372,288 PEG ratio: 0 WebAverage analysts price target $37 Buy rating Cellectis SA is a biopharmaceutical company, which engages in the research and development of genome engineering technology. The …

ATRA Stock Forecast, Price & News (Atara Biotherapeutics)

WebAccording to our current CLLS stock forecast, the value of Cellectis S.A. shares will rise by 5.17% and reach $ 2.05 per share by April 7, 2024. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).CLLS stock recorded 6/30 (20%) green days with 13.38% price volatility over the last 30 days. WebIt's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... mead gold and blood

Home Cellectis

WebApr 11, 2024 · The BALLI-01 study (evaluating UCART22) is actively enrolling patients with relapsed or refractory B-cell ALL after FCA lymphodepletion. NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing … WebCLLS Valuation Summary. CLLS's price/earnings ratio is -1; this is 104.27% lower than that of the median Healthcare stock. Over the past 96 months, CLLS's price/earnings ratio … WebApr 6, 2024 · A high-level overview of Cellectis S.A. (CLLS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. mead golf course allendea

CLLS Stock Price Cellectis S.A. ADR Stock Quote (U.S.: Nasdaq ...

Should I buy Cellectis (CLLS) - Zacks

Web22 hours ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Cellectis (CLLS) WebApr 12, 2024 · 7 brokers have issued twelve-month price targets for Atara Biotherapeutics' stock. Their ATRA share price forecasts range from $3.00 to $50.00. On average, they expect the company's share price to reach $19.25 in the next year. This suggests a possible upside of 594.9% from the stock's current price. View analysts price targets for ATRA … mead goffmanWebDec 5, 2024 · Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq. New York, NY, January 4, 2024 – Cellectis S.A. (“Cellectis” or the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced … mead goodgame empire

"Web22 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cellectis (CLLS) " - Clls stock price

Clls stock price

JASTIP IKEA INFORMA ACE, DLL on Instagram: "READY STOCK …

WebCLLS Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $7.67 with a … WebApr 6, 2024 · According to 10 analysts, the average rating for CLLS stock is "Buy." The 12-month stock price forecast is $23.95, which is an increase of 1,163.85% from the latest price.

Did you know?

WebApr 11, 2024 · The average 1 year target price among brokerages that have covered the stock in the last year is $8.57. A number of equities research analysts have issued reports on CLLS shares. WebMar 10, 2024 · See the latest Cellectis SA ADR stock price (NASDAQ:CLLS), related news, valuation, dividends and more to help you make your investing decisions.

WebApr 8, 2024 · 6 Wall Street analysts have issued 1 year price objectives for Cellectis' stock. Their CLLS share price forecasts range from $2.00 to … WebMar 17, 2024 · Check if CLLS Stock has a Buy or Sell Evaluation. CLLS Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Cellectis S.A. News. ... The Cellectis S.A. stock price gained 1.08% on the last trading day …

WebMar 31, 2024 · View Cellectis SA CLLS investment & stock information. Get the latest Cellectis SA CLLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and … WebFind the latest Cellectis S.A. (CLLS) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest Cellectis S.A. (CLLS) stock discussion in Yahoo Finance's forum. … Discover historical prices for CLLS stock on Yahoo Finance. View daily, weekly or … View the basic CLLS option chain and compare options of Cellectis S.A. on … Get the detailed quarterly/annual income statement for Cellectis S.A. (CLLS). Find … NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend … See Cellectis S.A. (CLLS) stock analyst estimates, including earnings and … Find out all the key statistics for Cellectis S.A. (CLLS), including valuation … Stocks sink after Fed minutes despite cooler inflation: Stock market news … Find the latest Cellectis S.A. (CLLS) stock quote, history, news and other vital … At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio …

WebFind real-time CLLS - Cellectis SA stock quotes, company profile, news and forecasts from CNN Business.

WebCLLS Stock Price Today. Cellectis S.A. (CLLS) stock declined over-17.70% intraday to trade at $2.51 a share on NASDAQ.The stock opened with a loss of-25.90% at $2.26 and touched an intraday high of $2.54, falling-17.70% against the last close of $3.05.The Cellectis S.A. in stock market went to a low of $2.25 during the session. mead green chathamWebApr 11, 2024 · The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $8.57. A number of research firms recently commented on CLLS. mead gravity water mead grand tour in the eighteenth centuryWebApr 10, 2024 · CLLS: Cellectis options chain stock quote. Get the latest options chain stock quote information from Zacks Investment Research. meadgate schoolWebApr 6, 2024 · According to 10 analysts, the average rating for CLLS stock is "Buy." The 12-month stock price forecast is $23.95, which is an increase of 1,163.85% from the latest … mead gravity went upWebAccording to our current CLLS stock forecast, the value of Cellectis S.A. shares will rise by 5.17% and reach $ 2.05 per share by April 7, 2024. According to our technical indicators, … mead g r sWebAverage analysts price target $37 Buy rating Cellectis SA is a biopharmaceutical company, which engages in the research and development of genome engineering technology. The company operates through the followingEntry level $16 = Target price $19.50 = Stop loss $15 Significant break above 200ma. Average analysts price target $37 Buy rating ... mead green layhams road keston br2 6ar